Hollencrest Capital Management’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Hollencrest Capital Management’s Portfolio TTHI Stock Details TTHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-188,596	Closed	-$283K	–	398
2016 Q3	$283K	Hold	188,596	–	–	0.04%	256
2016 Q2	$277K	Hold	188,596	–	–	0.04%	288
2016 Q1	$241K	Buy	188,596 +26,400	+16%	+$30.5K	0.04%	298
2015 Q4	$311K	Hold	162,196	–	–	0.06%	259
2015 Q3	$290K	Hold	162,196	–	–	0.05%	250
2015 Q2	$341K	Hold	162,196	–	–	0.05%	247
2015 Q1	$1.11M	Hold	162,196	–	–	0.15%	110
2014 Q4	$1.09M	Hold	162,196	–	–	0.14%	112
2014 Q3	$1.11M	Hold	162,196	–	–	0.15%	105
2014 Q2	$1.11M	Buy	162,196 +19,194	+13%	+$111K	0.15%	109
2014 Q1	$1.14M	Hold	143,002	–	–	0.17%	102
2013 Q4	$810K	Buy	+143,002	New	+$733K	0.13%	116

Hollencrest Capital Management's TTHI Position: Q4 2016 in Review

Hollencrest Capital Management sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q4 2016, closing a stake of 188,596 shares — an estimated $283K sold.

Hollencrest Capital Management first reported a position in TTHI in Q4 2013 and held it in 12 quarters. The position peaked at $1.14M in Q1 2014. 0 funds tracked by Wall St. Rank hold TTHI as of Q4 2016.

Hollencrest Capital Management reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q4 2016 after selling out during the quarter.
Hollencrest Capital Management sold 188,596 TRANSITION THERAPEUTICS INC (CANADA) shares in Q4 2016, an estimated $283K.
Hollencrest Capital Management first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q4 2013 and held it in 12 quarters.
Hollencrest Capital Management's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $1.14M in Q1 2014.
0 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q4 2016.

Based on Hollencrest Capital Management's 13F filing for Q4 2016, filed 30 Jan 2017.